Clinical case shows improved outcomes from genetic engineering therapy in a patient with orbital wall defects, suggesting a novel approach for chronic rhinosinusitis management.
Chronic rhinosinusitis is an inflammatory disease of the upper respiratory tract, in most cases leading to the formation of polyps in the nasal passages and paranasal sinuses. Due to its complex pathogenesis, which includes the interaction of various factors, including genetic predisposition, allergic reactions, infectious agents, and immune mechanisms, this disease can significantly impair the quality of life of patients. Traditional methods of treatment, such as drug therapy and surgery, do not always lead to the desired result. In recent years, the attention of specialists has been attracted by genetic engineering therapy as a promising method of treating chronic polypous rhinosinusitis, especially in complex cases such as the presence of defects in anatomical structures.
No takes yet. Share an insight, caveat, or question.
Abdulkerimov et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: